TissGeneSummary for TM4SF5 |
Gene summary |
Basic gene information | Gene symbol | TM4SF5 |
Gene name | transmembrane 4 L six family member 5 | |
Synonyms | - | |
Cytomap | UCSC genome browser: 17p13.3 | |
Type of gene | protein-coding | |
RefGenes | NM_003963.2, | |
Description | tetraspan transmembrane protein L6Htransmembrane 4 L6 family member 5transmembrane 4 superfamily member 5 | |
Modification date | 20141207 | |
dbXrefs | MIM : 604657 | |
HGNC : HGNC | ||
Ensembl : ENSG00000142484 | ||
HPRD : 06877 | ||
Vega : OTTHUMG00000090776 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_TM4SF5 | |
BioGPS: 9032 | ||
Pathway | NCI Pathway Interaction Database: TM4SF5 | |
KEGG: TM4SF5 | ||
REACTOME: TM4SF5 | ||
Pathway Commons: TM4SF5 | ||
Context | iHOP: TM4SF5 | |
ligand binding site mutation search in PubMed: TM4SF5 | ||
UCL Cancer Institute: TM4SF5 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | KidneyLiver | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | KIRC,KIRP,KICHLIHC | |
Reference showing the relevant tissue of TM4SF5 | ||
Description by TissGene annotations |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for TM4SF5 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
KICH | -3.875004598 | 1.015603402 | -4.890608 | 3.33E-09 | 1.91E-08 |
KIRC | 3.142540902 | 1.532321458 | 1.610219444 | 0.000252 | 0.000510608 |
KIRP | -0.393884098 | 2.420312777 | -2.814196875 | 9.49E-05 | 0.000325828 |
Top |
TissGene-miRNA for TM4SF5 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for TM4SF5 |
TissGeneSNV for TM4SF5 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.R113Q | SKCM | 2 |
p.G133R | SKCM | 1 |
p.G174V | COAD | 1 |
p.T16A | UCEC | 1 |
p.R113Q | UCEC | 1 |
p.M1L | STAD | 1 |
p.T157M | KIRP | 1 |
p.C2Y | PRAD | 1 |
p.Q46X | CHOL | 1 |
p.W154C | LUAD | 1 |
p.G4R | SKCM | 1 |
p.L177P | COAD | 1 |
p.R113Q | READ | 1 |
p.P63A | HNSC | 1 |
p.E146Q | CESC | 1 |
p.R150H | SKCM | 1 |
p.Y103* | ACC | 1 |
p.C173Y | SARC | 1 |
p.L119V | STAD | 1 |
p.N138D | STAD | 1 |
p.Q46E | LUSC | 1 |
p.G122S | SKCM | 1 |
Top |
TissGeneCNV for TM4SF5 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for TM4SF5 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Top |
TissGeneNet for TM4SF5 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for TM4SF5 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for TM4SF5 |
TissGeneDrug for TM4SF5 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for TM4SF5 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C2239176 | Liver carcinoma | 9 | BeFree |
umls:C0027627 | Neoplasm Metastasis | 2 | BeFree |
umls:C0596263 | Carcinogenesis | 2 | BeFree |
umls:C0024121 | Lung Neoplasms | 1 | BeFree |
umls:C0024623 | Malignant neoplasm of stomach | 1 | BeFree |
umls:C0260037 | Multiple tumors | 1 | BeFree |
umls:C0346957 | Disseminated Malignant Neoplasm | 1 | BeFree |
umls:C0699791 | Stomach Carcinoma | 1 | BeFree |
umls:C1519670 | Tumor Angiogenesis | 1 | BeFree |